Should patients manage their own oral anticoagulation therapy?

Reviews in Clinical Gerontology

Volumn 12, Issue 4, 2003, Pages 275-281

  Marzolini, Maria ^a   Wynne, Hilary A ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; WARFARIN;

ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; EDITORIAL; HUMAN; INTERNATIONAL STANDARD UNIT; MANAGEMENT; MONITOR; PATIENT SATISFACTION; PROTHROMBIN TIME; QUALITY OF LIFE; THROMBOEMBOLISM; TRAINING;

EID: 0037696872     PISSN: 09592598     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0959259802012418     Document Type: Editorial

References (20)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomised controlled trials. Arch Intern Med 1994; 154: 1449-57.
2. Group, O.A.M.S. Prothrombin measurement using a patient self-testing system. Am J Clin Pathol 2001; 115: 280-87.
3. Douketis JD, Milne J, Ginsberg JS. Accuracy of a portable international normalization ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-17.
4. Caliezi C, Waber M, Pfiffner D et al. Patient self-monitoring of oral anticoagulation with Coaguchek. Schweiz Med Wochenschr 2000; 130: 916-23.
5. Ansell JE, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Int Med 1995; 155: 2185-89.
6. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomised controlled trial. JAMA 1999; 281: 145-50.
7. Cromheecke ME., Colly LP, de Mol BJM et al. International Normalized Ratio Self-Management after mechanical heart valve. Lancet 2000; 356: 97-102.
8. Hasenkam JM, Kimose HH, Knudsen L, Gronnesby H, Halborg J, Christensen TD, Attermann J, Pilegaard HK. Self-management of oral anticoagulant therapy after heart valve replacement. Eur J Cardio-Thorac Surg 1997; 11: 935-42.
9. Kortke H, Minami K, Breymannt et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial. Z Kardiol 2001; 90: 118-24.
10. Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemostasis 2000; 83: 661-65.
11. Samsa GP. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000; 9: 283-92.
12. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomised, controlled trial. Ann Intern Med 2000; 133: 687-95.
13. Heidinger KS, Taborski U, Muller-Berghaus G. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis. Thromb Res 2000; 98: 287-93.
14. Voller H, Glatz J, Taborski U et al. Background and evaluation plan of a study on self-management of anticoagulation in patients with non-valvular atrial fibrillation (SMAAF Study). Z Kardiol 2000; 89: 284-88.
15. Kulinna W, Wenzel T, Heene DL, Harenberg J. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Sem Thromb Hemostasis 1999; 25: 123-26.
16. Anderson DR, Hirsh J. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Int Med 1993; 153: 1441-47.
17. Morsdorf S, Erdlenbruch K, Taborski U et al. Training of patients for self-management of oral anticoagulant therapy: Standards, patient suitability, and clinical aspects. Sem Thromb Hemostasis 1999; 25: 109-16.
18. Cosmi B, Palareti G, Carpanedo M et al. Assessment of patient capability of self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (Coaguchek). Haematol 2000; 85: 826-31.
19. Eckman MH, Pauker SG. Making decisions about anti-thrombotic therapy in heart disease. Chest 1995; 108(suppl): 457-70.
20. Ansell JE. Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996; 132: 1095-1100.